HEXUN BIOSCIENCES CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.8 TWD | +2.43% |
|
+6.01% | +16.98% |
| 1 week | +6.01% | ||
| Current month | +0.66% |
| 1 day | +2.43% | ||
| 1 week | +6.01% | ||
| Current month | +0.66% | ||
| 1 month | +26.33% | ||
| 3 months | +38.32% | ||
| 6 months | +14.16% | ||
| Current year | +16.98% |
1 week
72.70
77.70
1 month
59.5077.70
Current year
40.0077.70
1 year
40.0099.00
3 years
40.0099.00
5 years
40.0099.00
10 years
40.0099.00
HeXun Biosciences Co Ltd is a Taiwan-based company primarily engaged in the drug development business. The Company's products and services are mainly new drug development and sales, contract development and manufacturing services, testing services and other services. The Company's cellular products are categorized into allogeneic mesenchymal stem cell drugs and autologous cell medical technology development cellular products. The Company is also engaged in the provision of aseptic filling services, Good Tissue Practice (GTP) laboratory setup and quality documentation counseling services, and laboratory information management systems. The Company sells its products and services primarily domestically.
| 1st Jan change | Capi. | |
|---|---|---|
| +16.98% | 11Cr | |
| +46.19% | 5.67TCr | |
| -6.14% | 3.94TCr | |
| +39.19% | 3.9TCr | |
| -6.65% | 2.69TCr | |
| +12.33% | 2.67TCr | |
| -21.78% | 1.9TCr | |
| -0.35% | 1.23TCr | |
| +24.18% | 1.23TCr | |
| +28.38% | 1.2TCr |
- Stock Market
- Equities
- 6986 Stock
